Home › Funds › Artia Global Partners LP › RAPP

Artia Global Partners LP position in RAPP

RAPPORT THERAPEUTICS INC · Health Care

Artia Global Partners LP reported holding 138,508 shares of RAPP (RAPPORT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.8M, representing 1.07% of its reported portfolio and ranking #21 among its reported holdings. Artia Global Partners LP has disclosed RAPP holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)138.51K sh
Reported value held$5.77M
Portfolio Weight1.07%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's RAPP position evolved

Artia Global Partners LP first disclosed a stake in RAPP in Q3 2025 at 64,608 shares (US$1.9M). The position peaked in Q2 2026 at 138,508 shares, worth US$5.8M. Across 4 filings, Artia Global Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 138,508 shares valued at US$5.8M. Notable position changes include a 114% increase in Q4 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 64.61K $1.92M New
Q4 2025 138.51K $4.20M Add
Q1 2026 138.51K $4.33M Hold
Q2 2026 138.51K $5.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RAPP and 13F data

RAPP (RAPPORT THERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in RAPP — the largest reported positions include TRV GP V, LLC (US$261.7M), ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RAPP

All RAPP fund holders →

FAQ

How long has Artia Global Partners LP held RAPP?

Artia Global Partners LP has disclosed RAPP holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Artia Global Partners LP's current position in RAPP?

As of Q2 2026, Artia Global Partners LP holds 138.51K shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $5.77M, representing 1.07% of its reported portfolio and ranking #21.

Has Artia Global Partners LP been buying or selling RAPP?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in RAPP. The position peaked in Q2 2026 at 138.51K shares.

Which other funds hold RAPP?

Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.